Surgery Does Not Improve Survival in Patients With Isolated Severe Tricuspid Regurgitation
- PMID: 31071413
- PMCID: PMC8890054
- DOI: 10.1016/j.jacc.2019.04.028
Surgery Does Not Improve Survival in Patients With Isolated Severe Tricuspid Regurgitation
Abstract
Background: Patients with isolated tricuspid regurgitation (TR) in the absence of left-sided valvular dysfunction are often managed nonoperatively.
Objectives: The purpose of this study was to assess the impact of surgery for isolated TR, comparing survival for isolated severe TR patients who underwent surgery with those who did not.
Methods: A longitudinal echocardiography database was used to perform a retrospective analysis of 3,276 adult patients with isolated severe TR from November 2001 to March 2016. All-cause mortality for patients who underwent surgery versus those who did not was analyzed in the entire cohort and in a propensity-matched sample. To assess the possibility of immortal time bias, the analysis was performed considering time from diagnosis to surgery as a time-dependent covariate.
Results: Of 3,276 patients with isolated severe TR, 171 (5%) underwent tricuspid valve surgery, including 143 (84%) repairs and 28 (16%) replacements. The remaining 3,105 (95%) patients were medically managed. When considering surgery as a time-dependent covariate in a propensity-matched sample, there was no difference in overall survival between patients who received medical versus surgical therapy (hazard ratio: 1.34; 95% confidence interval: 0.78 to 2.30; p = 0.288). In the subgroup that underwent surgery, there was no difference in survival between tricuspid repair versus replacement (hazard ratio: 1.53; 95% confidence interval: 0.74 to 3.17; p = 0.254).
Conclusions: In patients with isolated severe TR, surgery is not associated with improved long-term survival compared to medical management alone after accounting for immortal time bias.
Keywords: immortal time bias; isolated severe tricuspid regurgitation; survival analysis.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
Comment in
-
Surgery for Isolated Tricuspid Regurgitation: Limitations of Observational Analyses.J Am Coll Cardiol. 2019 Aug 13;74(6):726-728. doi: 10.1016/j.jacc.2019.06.035. J Am Coll Cardiol. 2019. PMID: 31395121 No abstract available.
-
Surgery Might Not Improve Survival, But Quality of Life.J Am Coll Cardiol. 2019 Dec 3;74(22):2829-2830. doi: 10.1016/j.jacc.2019.08.1068. J Am Coll Cardiol. 2019. PMID: 31779805 No abstract available.
-
What Is the Best Option in Patients With Isolated Severe Tricuspid Regurgitation?J Am Coll Cardiol. 2019 Dec 3;74(22):2829. doi: 10.1016/j.jacc.2019.09.049. J Am Coll Cardiol. 2019. PMID: 31779806 No abstract available.
Similar articles
-
Clinical outcome of isolated tricuspid regurgitation.JACC Cardiovasc Imaging. 2014 Dec;7(12):1185-94. doi: 10.1016/j.jcmg.2014.07.018. Epub 2014 Nov 5. JACC Cardiovasc Imaging. 2014. PMID: 25440592
-
Characteristics and prognosis of patients with significant tricuspid regurgitation.Arch Cardiovasc Dis. 2019 Oct;112(10):604-614. doi: 10.1016/j.acvd.2019.06.011. Epub 2019 Sep 23. Arch Cardiovasc Dis. 2019. PMID: 31558358
-
Outcomes and Echocardiographic Follow-up After Surgical Management of Tricuspid Regurgitation in Patients With Transvenous Right Ventricular Leads.Mayo Clin Proc. 2021 Aug;96(8):2133-2144. doi: 10.1016/j.mayocp.2020.11.034. Epub 2021 Jul 3. Mayo Clin Proc. 2021. PMID: 34226024
-
Management of tricuspid valve regurgitation: Position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease.Eur J Cardiothorac Surg. 2017 Dec 1;52(6):1022-1030. doi: 10.1093/ejcts/ezx279. Eur J Cardiothorac Surg. 2017. PMID: 28950325 Review.
-
Transcatheter Therapies for Treating Tricuspid Regurgitation.J Am Coll Cardiol. 2016 Apr 19;67(15):1829-1845. doi: 10.1016/j.jacc.2016.01.063. J Am Coll Cardiol. 2016. PMID: 27081024 Review.
Cited by
-
Atrial Functional Tricuspid Regurgitation Associated With Atrial Standstill.Cureus. 2024 Sep 17;16(9):e69577. doi: 10.7759/cureus.69577. eCollection 2024 Sep. Cureus. 2024. PMID: 39421093 Free PMC article.
-
Comparative analysis of MitraClip/TriClip and PASCAL in transcatheter tricuspid valve repair for tricuspid regurgitation: a systematic review and meta-analysis.BMC Cardiovasc Disord. 2024 Oct 14;24(1):557. doi: 10.1186/s12872-024-04201-6. BMC Cardiovasc Disord. 2024. PMID: 39402473 Free PMC article.
-
Exercise testing in patients with tricuspid regurgitation undergoing transcatheter tricuspid valve intervention.Clin Res Cardiol. 2024 Oct 9. doi: 10.1007/s00392-024-02554-8. Online ahead of print. Clin Res Cardiol. 2024. PMID: 39382705
-
New Therapeutic Advances in the Management of Tricuspid Valve Regurgitation.J Clin Med. 2024 Aug 6;13(16):4599. doi: 10.3390/jcm13164599. J Clin Med. 2024. PMID: 39200742 Free PMC article. Review.
-
Comparison of clinical and echocardiographic outcomes between mini-thoracotomy transatrial LuX-Valve transcatheter and surgical tricuspid valve replacement.Front Cardiovasc Med. 2024 Aug 5;11:1417757. doi: 10.3389/fcvm.2024.1417757. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39161660 Free PMC article.
References
-
- Haddad F, Doyle R, Murphy DJ, Hunt SA Right Ventricular Function in Cardiovascular Disease, Part II. Circulation 2008;117(13):1717–31. - PubMed
-
- Kundi H, Popma JJ, Cohen DJ, et al. Prevalence and Outcomes of Isolated Tricuspid Valve Surgery Among Medicare Beneficiaries. Am J Cardiol 2018;0(0). - PubMed
-
- Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004;43(3):405–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
